These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Leishmania major: Reactive oxygen species and interferon gamma induction by soluble lipophosphoglycan of stationary phase promastigotes. Kavoosi G; Ardestani SK; Kariminia A; Abolhassani M; Turco SJ Exp Parasitol; 2006 Dec; 114(4):323-8. PubMed ID: 16759653 [TBL] [Abstract][Full Text] [Related]
46. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120 [TBL] [Abstract][Full Text] [Related]
48. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Moll H; Mitchell GF; McConville MJ; Handman E Infect Immun; 1989 Nov; 57(11):3349-56. PubMed ID: 2807527 [TBL] [Abstract][Full Text] [Related]
49. Induction of interleukin 1 alpha in murine macrophages infected in vitro with different species and strains of Leishmania. Delfino D; Chiofalo MS; Riggio G; Angelici MC; Gramiccia M; Gradoni L; Iannello D Microb Pathog; 1995 Feb; 18(2):73-80. PubMed ID: 7643744 [TBL] [Abstract][Full Text] [Related]
50. Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin XI. Arango Duque G; Fukuda M; Turco SJ; Stäger S; Descoteaux A J Immunol; 2014 Sep; 193(5):2363-72. PubMed ID: 25063865 [TBL] [Abstract][Full Text] [Related]
51. Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants. Garami A; Mehlert A; Ilg T Mol Cell Biol; 2001 Dec; 21(23):8168-83. PubMed ID: 11689705 [TBL] [Abstract][Full Text] [Related]
53. Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes. Passero LF; Marques C; Vale-Gato I; Corbett CE; Laurenti MD; Santos-Gomes G Arch Dermatol Res; 2012 Jan; 304(1):47-55. PubMed ID: 21882046 [TBL] [Abstract][Full Text] [Related]
54. Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines. Nikolaev AV; Sizova OV Biochemistry (Mosc); 2011 Jul; 76(7):761-73. PubMed ID: 21999537 [TBL] [Abstract][Full Text] [Related]
55. Lipophosphoglycan of the protozoan parasite Leishmania: stage- and species-specific importance for colonization of the sandfly vector, transmission and virulence to mammals. Ilg T Med Microbiol Immunol; 2001 Nov; 190(1-2):13-7. PubMed ID: 11770101 [TBL] [Abstract][Full Text] [Related]
56. Parasite escape mechanisms: the role of Leishmania lipophosphoglycan on the human phagocyte functions. A review. Panaro MA; Panunzio M; Jirillo E; Marangi A; Brandonisio O Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):595-605. PubMed ID: 8576549 [TBL] [Abstract][Full Text] [Related]
57. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Späth GF; Garraway LA; Turco SJ; Beverley SM Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9536-41. PubMed ID: 12869694 [TBL] [Abstract][Full Text] [Related]
58. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation. Datta N; Mukherjee S; Das L; Das PK Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468 [TBL] [Abstract][Full Text] [Related]